Na Shen

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Inflammatory Response

Top Venues

ACS biomaterials science & engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Fuxin Xue, Haochen Yao, Linjie Cui, Yue Huang, Changlu Shao, Na Shen, Junli Hu, Zhaohui Tang, Xuesi Chen
An Fc Binding Peptide-Based Facile and Versatile Build Platform for Multispecific Antibodies. Nano letters (2023)
Haochen Yao, Na Shen, Guofeng Ji, Juanjuan Huang, Jiali Sun, Guoqing Wang, Zhaohui Tang, Xuesi Chen
Cisplatin Nanoparticles Promote Intratumoral CD8 + T Cell Priming via Antigen Presentation and T Cell Receptor Crosstalk. Nano letters 22 (8) (2022)
Yinan Wang, Na Shen, Shuchun Li, Haiyang Yu, Yue Wang, Zhilin Liu, Liying Han, Zhaohui Tang
Synergistic Therapy for Cervical Cancer by Codelivery of Cisplatin and JQ1 Inhibiting Plk1-Mutant Trp53 Axis. Nano letters 21 (6) (2021)
Na Shen, Jing Wu, Chenguang Yang, Haiyang Yu, Shengcai Yang, Tete Li, Jingtao Chen, Zhaohui Tang, Xuesi Chen
Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment. Nano letters 19 (11) (2019)
Na Shen, Jian Jiang, Dawei Zhang, Guanyi Wang, Shixian Lv, Yanjie Jia, Zhaohui Tang, Xuesi Chen
Bortezomib Increases the Cancer Therapeutic Efficacy of Poly(amino acid)-Doxorubicin. ACS biomaterials science & engineering 4 (6) (2017)